135 related articles for article (PubMed ID: 20522710)
1. Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma.
Strothmeyer AM; Papaioannou D; Dühren-von Minden M; Navarrete M; Zirlik K; Heining-Mikesch K; Veelken H
Blood; 2010 Sep; 116(10):1734-6. PubMed ID: 20522710
[TBL] [Abstract][Full Text] [Related]
2. Evidence for idiotype-directed immunosurveillance is restricted to follicular lymphoma and attributable to somatic hypermutation.
Papaioannou D; Strothmeyer AM; Dühren-von Minden M; Keppler-Hafkemeyer A; Zirlik K; Mikesch K; van Bergen CA; Navarrete MA; Veelken H
Haematologica; 2015 Apr; 100(4):e143-6. PubMed ID: 25616573
[No Abstract] [Full Text] [Related]
3. Analysis of the intraclonal diversity of HLA-A0201-restricted T lymphocyte epitopes in follicular lymphoma idiotype.
Molinier-Frenkel V; Popa N; Poulot V; Chaise C; Marquet J; Haioun C; Gaulard P; Farcet JP; Delfau-Larue MH
Br J Haematol; 2006 Feb; 132(4):459-68. PubMed ID: 16412018
[TBL] [Abstract][Full Text] [Related]
4. Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.
Baskar S; Kobrin CB; Kwak LW
J Clin Invest; 2004 May; 113(10):1498-510. PubMed ID: 15146248
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with protein-pulsed or idiotype-transduced dendritic cells.
Osterroth F; Garbe A; Fisch P; Veelken H
Blood; 2000 Feb; 95(4):1342-9. PubMed ID: 10666209
[TBL] [Abstract][Full Text] [Related]
6. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
Gricks CS; Rawlings E; Foroni L; Madrigal JA; Amlot PL
Cancer Res; 2001 Jul; 61(13):5145-52. PubMed ID: 11431353
[TBL] [Abstract][Full Text] [Related]
7. Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells.
Warncke M; Buchner M; Thaller G; Dodero A; Bulashevska A; Pfeifer D; Timmer J; Veelken H
Cancer Immunol Immunother; 2011 Jan; 60(1):49-60. PubMed ID: 20848095
[TBL] [Abstract][Full Text] [Related]
8. Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma.
Navarrete MA; Heining-Mikesch K; Schüler F; Bertinetti-Lapatki C; Ihorst G; Keppler-Hafkemeyer A; Dölken G; Veelken H
Blood; 2011 Feb; 117(5):1483-91. PubMed ID: 21045197
[TBL] [Abstract][Full Text] [Related]
9. Vaccination strategies in follicular lymphoma.
Kannan S; Neelapu SS
Curr Hematol Malig Rep; 2009 Oct; 4(4):189-95. PubMed ID: 20425407
[TBL] [Abstract][Full Text] [Related]
10. T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma.
Hansson L; Rabbani H; Fagerberg J; Osterborg A; Mellstedt H
Blood; 2003 Jun; 101(12):4930-6. PubMed ID: 12576325
[TBL] [Abstract][Full Text] [Related]
11. Identification of human idiotype-specific T cells in lymphoma and myeloma.
Weng J; Neelapu SS; Woo AF; Kwak LW
Curr Top Microbiol Immunol; 2011; 344():193-210. PubMed ID: 20549471
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
14. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.
Bertinetti C; Simon F; Zirlik K; Heining-Mikesch K; Pfeifer D; Osterroth F; Rosenthal FM; Veelken H
Eur J Haematol; 2006 Nov; 77(5):395-402. PubMed ID: 16879605
[TBL] [Abstract][Full Text] [Related]
15. Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.
Neelapu SS; Baskar S; Gause BL; Kobrin CB; Watson TM; Frye AR; Pennington R; Harvey L; Jaffe ES; Robb RJ; Popescu MC; Kwak LW
Clin Cancer Res; 2004 Dec; 10(24):8309-17. PubMed ID: 15623607
[TBL] [Abstract][Full Text] [Related]
16. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
[TBL] [Abstract][Full Text] [Related]
17. Follicular lymphoma: a model of lymphoid tumor progression in man.
Zelenetz AD; Campbell MJ; Bahler DW; Takahashi S; Oren R; Esserman L; Umetsu DT; Kwak LW; Maloney DG; Brown S
Ann Oncol; 1991 Feb; 2 Suppl 2():115-22. PubMed ID: 2049308
[TBL] [Abstract][Full Text] [Related]
18. The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.
Trolle T; McMurtrey CP; Sidney J; Bardet W; Osborn SC; Kaever T; Sette A; Hildebrand WH; Nielsen M; Peters B
J Immunol; 2016 Feb; 196(4):1480-7. PubMed ID: 26783342
[TBL] [Abstract][Full Text] [Related]
19. Translational development of vaccination strategies in follicular NHL.
Sakamaki I; Qin H; Kwak LW
Best Pract Res Clin Haematol; 2011 Jun; 24(2):295-304. PubMed ID: 21658625
[TBL] [Abstract][Full Text] [Related]
20. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]